Previous Article |
Table of Contents
| Next Article
GENETICS
Distinctions in the specificity of E2F function revealed by gene expression signatures




, ¶
*Duke Institute for Genome Sciences and Policy,
Department of Molecular Genetics and Microbiology, Medical Center, and
Institute for Statistics and Decision Sciences, Duke University, Durham, NC 27710
Edited by Ed Harlow, Harvard Medical School, Boston, MA and approved September 9, 2005 (received for review May 25, 2005)
The E2F family of transcription factors provides essential activities for coordinating the control of cellular proliferation and cell fate. Both E2F1 and E2F3 proteins have been shown to be particularly important for cell proliferation, whereas the E2F1 protein has the capacity to promote apoptosis. To explore the basis for this specificity of function, we used DNA microarray analysis to probe for the distinctions in the two E2F activities. Gene expression profiles that distinguish either E2F1- or E2F3-expressing cells from quiescent cells are enriched in genes encoding cell cycle and DNA replication activities, consistent with many past studies. E2F1 profile is also enriched in genes known to function in apoptosis. We also identified patterns of gene expression that specifically differentiate the activity of E2F1 and E2F3; this profile is enriched in genes known to function in mitosis. The specificity of E2F function has been attributed to protein interactions mediated by the marked box domain, and we now show that chimeric E2F proteins generate expression signatures that reflect the origin of the marked box, thus linking the biochemical mechanism for specificity of function with specificity of gene activation.
DNA microarray | transcriptional control
Conflict of interest statement: No conflicts declared.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: MEF, mouse embryo fibroblast; HA, hemagglutinin; CMV, cytomegalovirus; Ad, adenovirus.
Present address: Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY 40536.
¶ To whom correspondence should be addressed. E-mail: j.nevins{at}duke.edu.
© 2005 by The National Academy of Sciences of the USA
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
M. Truscott, R. Harada, C. Vadnais, F. Robert, and A. Nepveu p110 CUX1 Cooperates with E2F Transcription Factors in the Transcriptional Activation of Cell Cycle-Regulated Genes Mol. Cell. Biol., May 15, 2008; 28(10): 3127 - 3138. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yurkova, J. Shaw, K. Blackie, D. Weidman, R. Jayas, B. Flynn, and L. A. Kirshenbaum The Cell Cycle Factor E2F-1 Activates Bnip3 and the Intrinsic Death Pathway in Ventricular Myocytes Circ. Res., February 29, 2008; 102(4): 472 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Harada, C. Vadnais, L. Sansregret, L. Leduy, G. Berube, F. Robert, and A. Nepveu Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes Nucleic Acids Res., January 17, 2008; 36(1): 189 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Srinivasan, C. N. Mayhew, S. Schwemberger, W. Zagorski, and E. S. Knudsen RB Loss Promotes Aberrant Ploidy by Deregulating Levels and Activity of DNA Replication Factors J. Biol. Chem., August 17, 2007; 282(33): 23867 - 23877. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Lu, J. D. Wright, B. Belt, R. D. Cardiff, and J. M. Arbeit Hypoxia-Inducible Factor-1 Facilitates Cervical Cancer Progression in Human Papillomavirus Type 16 Transgenic Mice Am. J. Pathol., August 1, 2007; 171(2): 667 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McClellan, V. A. Ruzhynsky, D. N. Douda, J. L. Vanderluit, K. L. Ferguson, D. Chen, R. Bremner, D. S. Park, G. Leone, and R. S. Slack Unique Requirement for Rb/E2F3 in Neuronal Migration: Evidence for Cell Cycle-Independent Functions Mol. Cell. Biol., July 1, 2007; 27(13): 4825 - 4843. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lu, T. Bonome, Y. Li, A. A. Kamat, L. Y. Han, R. Schmandt, R. L. Coleman, D. M. Gershenson, R. B. Jaffe, M. J. Birrer, et al. Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma Cancer Res., February 15, 2007; 67(4): 1757 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Learn, P. E. Fecci, R. J. Schmittling, W. Xie, I. Karikari, D. A. Mitchell, G. E. Archer, Z. Wei, H. Dressman, and J. H. Sampson Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers Clin. Cancer Res., December 15, 2006; 12(24): 7306 - 7315. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mussi, C. Yu, B. W. O'Malley, and J. Xu Stimulation of Steroid Receptor Coactivator-3 (SRC-3) Gene Overexpression by a Positive Regulatory Loop of E2F1 and SRC-3 Mol. Endocrinol., December 1, 2006; 20(12): 3105 - 3119. [Abstract] [Full Text] [PDF] |
||||